Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reward-based Technology to Improve Opioid Use Disorder Treatment Initiation After an ED Visit - Phase 1

NCT05159362 is registered in ClinicalTrials.gov with Q2i, LLC as lead sponsor.

NCT NCT05159362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05159362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reward-based Technology to Improve Opioid Use Disorder Treatment Initiation After an ED Visit - Phase 1
Lead sponsor
Q2i, LLC
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2020
Completion date
March 1, 2021
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contingency management, medication for opioid-use disorder, opioid-use disorder